Drug-induced and iatrogenic infiltrative lung disease

Philippe Camus; Philippe Bonniaud; Annlyse Fanton; Clio Camus; Nicolas Baudaun; Pascal Foucher

doi:10.1016/j.ccm.2004.05.006

Drug-induced and iatrogenic infiltrative lung disease

Clin Chest Med. 2004 Sep;25(3):479-519, vi. doi: 10.1016/j.ccm.2004.05.006.

Authors

Philippe Camus¹, Philippe Bonniaud, Annlyse Fanton, Clio Camus, Nicolas Baudaun, Pascal Foucher

Affiliation

¹ Department of Pulmonary Disease and Intensive Care, Hôpital du Bocage, Faculté de Médecine at Université de Bourgogne, 2 Bd Marechal de Lattre de Tasigny, 21034 Dijon Cedex, France. philippe.camus@chu-dijon.fr

PMID: 15331188
DOI: 10.1016/j.ccm.2004.05.006

Abstract

At present more than 350 drugs are known to cause injury of the lung parenchyma,upper and lower airways, pulmonary circulation, pleura, mediastinum, lymph nodes,and neuromuscular system. Infiltrative lung disease (ILD) is the most common pattern of drug-induced injury. This article, which is clinically oriented rather than drug oriented, reviews the patterns of ILD produced by therapeutic drugs and radiation therapy.

Publication types

Review

MeSH terms

Amiodarone / adverse effects
Anti-Arrhythmia Agents / adverse effects
Drug-Related Side Effects and Adverse Reactions
Humans
Iatrogenic Disease*
Lung Diseases / chemically induced*
Lung Diseases / diagnosis
Lung Diseases / pathology
Methotrexate / adverse effects*
Pneumonia / chemically induced
Pulmonary Alveoli / pathology
Pulmonary Edema / chemically induced
Sarcoidosis, Pulmonary / chemically induced

Substances

Anti-Arrhythmia Agents
Amiodarone
Methotrexate